updated 3/17/2011 12:19:22 PM ET 2011-03-17T16:19:22

SOSUA BAY, Dominican Republic, March 17, 2011 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc. (Pink Sheets:PLBI) CEO, Armando Casciati, announced today that Proton Laborotories, Inc./RegenoBody will rescind the Agreement with Proton Laboratories, Inc. consummated in January of 2010 due to undisclosed liabilities and undisclosed claims that have arisen and have not been able to be resolved. Unfortunately, although we have completed the laboratory and are now ready to accept patients we are faced with the need to rescind our Agreement for the reasons stated and move forward as we were before the transaction with Proton Laboratories. We deeply regret having to take this step but have not been able to resolve the $500,000 + in claims and liabilities we were not told of and did not know existed at the time of the transaction. We have researched the issues over the last weeks and while there may be issues with the claims it is not our responsibility and we cannot afford to undertake that responsibility.  The rescission will leave Proton with the assets it had before the transaction with RegenoBody and will have its prior management and RegenoBody will continue as a private entity.  


This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this report are made as of the date hereof and the company undertakes no obligation to update such statements.

CONTACT: Proton Laboratories, Inc.
         Ed Alexander at: edalexander@idtusa.net or
         Jim Wheeler at:  jim@jasrwheeler.com

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com